VEGF-BMP2 gene therapy (Kazan Federal University)

N/A

Report date: 2024/09/19 15:13:37

Base Information

Drug NameVEGF-BMP2 gene therapy (Kazan Federal University)
Drug Alias NamepBud-VEGF-BMP2 plasmid gene therapy
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionVEGF gene stimulantsBone morphogenetic protein receptor type-2 agonists
TargetsBone morphogenetic protein receptor type-2Vascular endothelial growth factor
Therapy Area/IndicationsFractures, Bone
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesKazan Federal University
China Registration ClassN/A

Develop Information

Active CompaniesKazan Federal University
Inactive CompaniesN/A
Active IndicationsFractures, Bone
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A